Skip
Mission of Sihuan
Innovation for human health
Enjoy the video
News and Events
Declaration
Sihuan Metformin Hydrochloride Tablet Passes Consistency Evaluation
Sihuan Officially Starts Phase II Clinical Trial on Pirotinib in China
Che Fengsheng and His Team Visit Jiulongpo Hospital 2 for Work Guidance
Explore Sihuan Pharmaceutical
20+
years of development
600+
outstanding R&D personnel
3,000+
distributors
300+
patents
MORE
Innovative R&D
Continuously dedicate substantial investment in R&D, which is conducted at our R&D platform with international standards, while establishing cooperation with international industry players.
Our Products
As a key player in the healthcare industry, we have built a diversified product portfolio covering five major therapeutic areas: cardio-cerebral vascular system, central nervous system, metabolism, oncology and diabetes.